Merck & Co. Joins Competitive BTK Research Space With $2.7bn ArQule Buy

SOLD red stamp. Flat vector icon - Vector
Merck is buying ArQule for $2.7bn in cash
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Deals

More from Business